Targeting spinal microglia with fexofenadine-loaded nanoparticles prolongs pain relief in a rat model of neuropathic pain

Q Tran, TL Pham, HJ Shin, J Shin, N Shin… - … , Biology and Medicine, 2022 - Elsevier
Targeting microglial activation is emerging as a clinically promising drug target for
neuropathic pain treatment. Fexofenadine, a histamine receptor 1 antagonist, is a clinical …
被引用次数：5 相关文章

Targeting spinal microglia with fexofenadine-loaded nanoparticles prolongs pain relief in a rat model of neuropathic pain.

Q Tran, TL Pham, HJ Shin, J Shin, N Shin… - Nanomedicine …, 2022 - europepmc.org
Targeting microglial activation is emerging as a clinically promising drug target for
neuropathic pain treatment. Fexofenadine, a histamine receptor 1 antagonist, is a clinical …

[引用][C] Targeting spinal microglia with fexofenadine-loaded nanoparticles prolongs pain relief in a rat model of neuropathic pain

Q Tran, TL Pham, HJ Shin, J Shin, N Shin… - … , Biology and Medicine, 2022 - cir.nii.ac.jp
Targeting spinal microglia with fexofenadine-loaded nanoparticles prolongs pain relief in a rat
model of neuropathic pain | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Targeting spinal microglia with fexofenadine-loaded nanoparticles prolongs pain relief in a rat model of neuropathic pain

Q Tran, TL Pham, HJ Shin, J Shin… - Nanomedicine …, 2022 - pubmed.ncbi.nlm.nih.gov
Targeting microglial activation is emerging as a clinically promising drug target for
neuropathic pain treatment. Fexofenadine, a histamine receptor 1 antagonist, is a clinical …

Targeting spinal microglia with fexofenadine-loaded nanoparticles prolongs pain relief in a rat model of neuropathic pain

Q Tran, TL Pham, HJ Shin, J Shin… - Nanomedicine …, 2022 - khu.elsevierpure.com
Targeting microglial activation is emerging as a clinically promising drug target for
neuropathic pain treatment. Fexofenadine, a histamine receptor 1 antagonist, is a clinical …